Your browser doesn't support javascript.
loading
Loss of ARHGEF1 causes a human primary antibody deficiency.
Bouafia, Amine; Lofek, Sébastien; Bruneau, Julie; Chentout, Loïc; Lamrini, Hicham; Trinquand, Amélie; Deau, Marie-Céline; Heurtier, Lucie; Meignin, Véronique; Picard, Capucine; Macintyre, Elizabeth; Alibeu, Olivier; Bras, Marc; Molina, Thierry Jo; Cavazzana, Marina; André-Schmutz, Isabelle; Durandy, Anne; Fischer, Alain; Oksenhendler, Eric; Kracker, Sven.
Afiliação
  • Bouafia A; Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France.
  • Lofek S; Université Paris Descartes-Sorbonne Paris Cité, Imagine Institute, Paris, France.
  • Bruneau J; Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France.
  • Chentout L; Université Paris Descartes-Sorbonne Paris Cité, Imagine Institute, Paris, France.
  • Lamrini H; Department of Pathology, Hôpital Necker-Enfants Malades, Assistance Publique des Hôpitaux de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Trinquand A; Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France.
  • Deau MC; Université Paris Descartes-Sorbonne Paris Cité, Imagine Institute, Paris, France.
  • Heurtier L; Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France.
  • Meignin V; Université Paris Descartes-Sorbonne Paris Cité, Imagine Institute, Paris, France.
  • Picard C; Hématologie Biologique and INSERM UMR 1151, University Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Macintyre E; Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France.
  • Alibeu O; Université Paris Descartes-Sorbonne Paris Cité, Imagine Institute, Paris, France.
  • Bras M; Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France.
  • Molina TJ; Université Paris Descartes-Sorbonne Paris Cité, Imagine Institute, Paris, France.
  • Cavazzana M; Department of Pathology, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France.
  • André-Schmutz I; Université Paris Descartes-Sorbonne Paris Cité, Imagine Institute, Paris, France.
  • Durandy A; Primary Immunodeficiency Study Center, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Fischer A; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INSERM UMR 1163, Imagine Institute, Paris, France.
  • Oksenhendler E; Department of Paediatric Immunology, Hematology and Rheumatology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Kracker S; Hématologie Biologique and INSERM UMR 1151, University Paris Descartes, Sorbonne Paris Cité, Paris, France.
J Clin Invest ; 129(3): 1047-1060, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30521495
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Transdução de Sinais / Doenças da Imunodeficiência Primária Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Clin Invest Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Transdução de Sinais / Doenças da Imunodeficiência Primária Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Clin Invest Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos